product1 publisher
OpenAI Foundation puts $500,000 behind buying failed biotechs' files out of bankruptcy
The grant to 1Day Sooner is the smallest disclosed line in the Foundation's first health-data round. It pays for a feasibility test, because the group's two attempts to get drug company files this year both failed.
Publishers:technologyreview.com
Reality
- Evidence62
- Adoption20
- Hype gap+25
- Incentives68
- Confidence58